United States Antimony Corporation occupies a distinctive niche as the only scaled, fully integrated antimony producer in North America, spanning mining, milling, and smelting. That vertical integration—from company-owned ore in Montana to finished metal and oxide products—gives it a cost and supply-chain advantage at a time when Western buyers are actively seeking alternatives to Chinese-controlled antimony.
The company's medium-term positioning rests on two pillars. First, its status as the sole scaled U.S. supplier of military-grade antimony ingots under a DLA contract makes it a strategic asset in the defense-industrial base. Second, its expansion into adjacent critical minerals—tungsten through the Fostung property in Ontario and a planned hydrometallurgical joint venture in Idaho—broadens the revenue base beyond a single commodity. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Structural risks temper the story. The company reported operating losses in six of the prior seven fiscal years, holds no material patents on its processing techniques, and remains dependent on third-party and artisanal feedstock for a meaningful share of its input. Competitive threats from larger miners and the emergence of alternative Western supply could also pressure its first-mover advantage over time.
Several developments could materially influence investor sentiment in the coming quarters. The most immediate is commissioning of the Thompson Falls smelter expansion, targeted for mid-2026, which is central to meeting full-year 2026 revenue guidance of approximately $125 million. Management has noted the project ran roughly 30 days behind schedule on equipment deliveries, making the commissioning timeline a key execution metric.
Federal contract milestones represent another catalyst. The DLA has already placed a $10 million initial order to be filled in 2026, with a larger follow-on order discussed at premium pricing relative to spot levels. Additional government awards—the company has cited applications totaling roughly $274 million for hydromet and other initiatives—could provide non-dilutive funding if granted.
On the analyst front, sentiment has trended more optimistic but remains varied. H.C. Wainwright maintains a Buy rating and raised its price target to $10.25 in November 2025, while William Blair initiated coverage with an Outperform rating and modeled a substantially higher long-term fair value. Consensus 12-month price targets have generally clustered near $9–$10, below some firms' more bullish longer-term projections, underscoring a divergence between near-term valuation screens and multi-year growth assumptions.
The company's trajectory is tightly linked to geopolitical and policy dynamics rather than conventional consumer cycles. China's September 2024 export restrictions on antimony triggered a roughly five-fold price spike before artisanal supply pulled spot prices back toward the high single digits per pound. Future spot pricing will hinge on the durability of that export policy and the pace at which new global supply comes online.
Regulatory tailwinds are unusually direct. A domestic-sourcing requirement for military and government contractors takes effect in January 2027, which management argues is already prompting contractors to secure U.S.-based supply ahead of the deadline. Antimony's designation as a critical mineral also makes the company eligible for federal funding streams.
Macro forces cut both ways. Elevated interest rates raise the cost of capital for mining buildouts, while inflation pressures input and labor costs. Conversely, defense-industrial spending and the data-center buildout—antimony compounds are used in flame retardants for wiring and infrastructure—provide demand anchors less tied to the broader economic cycle.
The 2026 narrative centers on converting contracted demand into executed revenue. Management has reaffirmed guidance of roughly $125 million for the year, heavily weighted to the second half as the Thompson Falls expansion reaches full capacity and federal shipments accelerate. Analysts modeling the period anticipate a swing from near-breakeven results toward meaningful profitability as higher-margin, self-mined feedstock displaces purchased ore.
Longer term, several structural themes merit attention. The hydromet JV in Idaho—a modular facility targeting roughly 1,000 MTPM and a 2028 start—could meaningfully expand processing capacity while accepting a wider range of feedstock grades. The tungsten opportunity positions the company in another China-dominated critical mineral, with management citing substantial in-ground resource value pending updated reports. Zeolite offers a diversified, non-defense revenue stream with multi-decade resource life.
Margin sustainability will depend on the balance between premium government-contract pricing and lower spot prices for third-party feed. Capital allocation priorities—including the pursuit of non-dilutive government grants versus potential equity issuance—will shape per-share value. While consensus expectations and named-firm targets span a wide range, the unifying theme is that execution on capacity, contracts, and diversification, rather than commodity prices alone, will determine whether the company's strategic inflection materializes.
One resource I frequently use when analyzing names in the critical minerals space is Tickeron’s Trend Prediction Engine. It offers AI-powered forecasts that help assess whether a stock may trend bullish, bearish, or sideways over the coming weeks or months, providing a useful complement to fundamental work on execution timelines and contract milestones.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
UAMY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 31 of 36 cases where UAMY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 86%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where UAMY's RSI Oscillator exited the oversold zone, 22 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for UAMY just turned positive on October 22, 2026. Looking at past instances where UAMY's MACD turned positive, the stock continued to rise in 45 of 55 cases over the following month. The odds of a continued upward trend are 82%.
Following a +33.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where UAMY advanced for three days, in 203 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UAMY as a result. In 77 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UAMY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for UAMY entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. UAMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 88 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UAMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.332) is normal, around the industry mean (6.813). P/E Ratio (-21.692) is within average values for comparable stocks, (-0.701). UAMY's Projected Growth (PEG Ratio) (9.440) is very high in comparison to the industry average of (1.026). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. P/S Ratio (17.241) is also within normal values, averaging (283.864).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a producer of antimony products
Industry OtherMetalsMinerals